National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt.
- DOI
- 10.36401/jqsh-24-12
- Published
- 2024 Nov
- Container
- Global journal on quality and safety in healthcare
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.36401/jqsh-24-12,
title = {National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt.},
author = {Gamal M and Sedrak AS and Elsisi GH and Elagamy A and Seyam A and Eldebeiky M and Eldessoki R},
year = {2024},
journal = {Global journal on quality and safety in healthcare},
doi = {10.36401/jqsh-24-12},
url = {https://doi.org/10.36401/jqsh-24-12}
}RIS
TY - JOUR TI - National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt. AU - Gamal M AU - Sedrak AS AU - Elsisi GH AU - Elagamy A AU - Seyam A AU - Eldebeiky M AU - Eldessoki R PY - 2024 JO - Global journal on quality and safety in healthcare DO - 10.36401/jqsh-24-12 UR - https://doi.org/10.36401/jqsh-24-12 ER -
APA
M, G., AS, S., GH, E., A, E., A, S., M, E., & R, E. (2024). National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt.. Global journal on quality and safety in healthcare. https://doi.org/10.36401/jqsh-24-12
Source records
- pubmed · retrieved 2026-09-25T12:52:35.520Z